- Home
- FTCI vs COEP Comparison
FTCI vs COEP Comparison
Compare FTCI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTCI | COEP |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.0M | 100.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | FTCI | COEP |
|---|---|---|
| Price | $8.93 | $17.57 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.63 | N/A |
| AVG Volume (30 Days) | ★ 421.4K | 60.4K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $80,028,000.00 | $500,996.00 |
| Revenue This Year | $93.79 | N/A |
| Revenue Next Year | $165.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 39.53 | N/A |
| 52 Week Low | $2.13 | $2.31 |
| 52 Week High | $11.45 | $21.41 |
Technical Indicators
Market Signals| Indicator | FTCI | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 53.26 |
| Support Level | $8.10 | $17.25 |
| Resistance Level | $9.70 | $21.41 |
| Average True Range (ATR) | 1.00 | 1.56 |
| MACD | -0.04 | 0.26 |
| Stochastic Oscillator | 46.15 | 38.02 |
Price Performance
Historical ComparisonAbout FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.